close

Agreements

Date: 2016-12-02

Type of information: Nomination

Compound:

Company: CytRx Corporation (USA - CA)

Therapeutic area: Cancer - Oncology

Type agreement:

nomination

Action mechanism:

Disease:

Details:

* On December 2, 2016, CytRx Corporation announced the appointment of Earl Warren Brien, M.D., a noted sarcoma surgeon, industry consultant, and private healthcare investor, to its Board of Directors. Dr. Brien is a board certified orthopedic and sarcoma surgeon who currently serves as a Professor of Orthopedic Surgery and Surgical Director of the Sarcoma Service at Cedars-Sinai Medical Center in Los Angeles, California. He earned his medical degree from Howard University School of Medicine and completed fellowships at the Memorial Sloan-Kettering Cancer Center in Orthopedic Oncology and at the Hospital for Special Surgery at Cornell University. Over his more than twenty-year career, Dr. Brien has received numerous research grants, given over 140 scientific presentations, and been published in numerous peer-reviewed journals and books.

Financial terms:

Latest news:

Is general: Yes